SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Aion Therapeutic Inc. (ANTCF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 12/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ANTCF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.44
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.02
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$-0.08 |
$0.00 |
$-1.51M |
- |
| 2018 |
$0.00 |
$0.00 |
$-140.11K |
- |
| 2019 |
$-0.18 |
$0.00 |
$-4.93M |
- |
| 2020 |
$-0.02 |
$0.00 |
$-672.83K |
- |
| 2021 |
$-0.09 |
$0.00 |
$-8.27M |
- |
| 2022 |
$-0.03 |
$0.00 |
$-3.82M |
- |
| 2023 |
$0.00 |
$0.00 |
$-256.66K |
- |
| 2024 |
$-0.02 |
$367.48K |
$-6.29M |
-1710.9% |
